327
Views
2
CrossRef citations to date
0
Altmetric
Original Investigations

Mortality and acute somatic events following electroconvulsive therapy in patients with pre-existing somatic comorbidity – A register-based nationwide Danish cohort study

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 318-326 | Received 04 Mar 2021, Accepted 17 Oct 2021, Published online: 15 Nov 2021

References

  • Anon n.d. NICE guidance – the use of electroconvulsive therapy (ECT) – General Practice Notebook. Available from: https://gpnotebook.com/simplepage.cfm?ID=x20030512223733840010.
  • Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry off World Fed Soc Biol Psychiatry. 14:334–385.
  • Benbow SM, Shah A. 2002. A survey of the views of geriatric psychiatrists in the United Kingdom on the use of electroconvulsive therapy to treat physically ill people. Int J Geriatr Psychiatry. 17:956–961.
  • Blumberger DM, Seitz DP, Herrmann N, Kirkham JG, Ng R, Reimer C, Kurdyak P, Gruneir A, Rapoport MJ, Daskalakis ZJ, et al. 2017. Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sample. Acta Psychiatr Scand. 136(6):583–593.
  • Dolenc TJ, Barnes RD, Hayes DL, Rasmussen KG. 2004. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 27(9):1257–1263.
  • Ducharme S, Murray ED, Seiner SJ, Tayeb H, Legesse B, Price BH. 2015. Retrospective analysis of the short-term safety of ECT in patients with neurological comorbidities: a guide for pre-ECT neurological evaluations. J Neuropsychiatry Clin Neurosci. 27(4):311–321.
  • Duma A, Maleczek M, Panjikaran B, Herkner H, Karrison T, Nagele P. 2019. Major adverse cardiac events and mortality associated with electroconvulsive therapy: a systematic review and meta-analysis. Anesthesiology. 130(1):83–91.
  • Hundrup E, Osler M, Jørgensen MB. 2017. Time trends and variations in electroconvulsive treatment in Denmark 2008 to 2014: a nationwide register-based study. J Ect. 33(4):243–248.
  • Jauhar S, Young AH. 2021. Morbidity and mortality associated with electroconvulsive therapy: can we control for confounding? Lancet Psychiatry. 8:643–644.
  • Jørgensen MB, Rozing MP, Kellner CH, Osler M. 2020. Electroconvulsive therapy, depression severity and mortality: data from the Danish National Patient Registry. J Psychopharmacol. 34(3):273–279.
  • Kaster TS, Vigod SN, Gomes T, Sutradhar R, Wijeysundera DN, Blumberger DM. 2021. Risk of serious medical events in patients with depression treated with electroconvulsive therapy: a propensity score-matched, retrospective cohort study. Lancet Psychiatry. 8:686–695.
  • Kellner CH, Obbels J, Sienaert P. 2020. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand. 141:304–315.
  • Liang C-S, Chung C-H, Tsai C-K, Chien W-C. 2017. In-hospital mortality among electroconvulsive therapy recipients: a 17-year nationwide population-based retrospective study. Eur Psychiatry. 42:29–35.
  • Magid M, Lapid MI, Sampson SM, Mueller PS. 2005. Use of electroconvulsive therapy in a patient 10 days after myocardial infarction. J Ect. 21:182–185.
  • Meyer JP, Swetter SK, Kellner CH. 2020. Electroconvulsive therapy in geriatric psychiatry: a selective review. Clin. Geriatr. Med. 36:265–279.
  • Mueller PS, Barnes RD, Varghese R, Nishimura RA, Rasmussen KG. 2007. The safety of electroconvulsive therapy in patients with severe aortic stenosis. Mayo Clin Proc. 82:1360–1363.
  • Mueller PS, Schak KM, Barnes RD, Rasmussen KG. 2006. Safety of electroconvulsive therapy in patients with asthma. Neth J Med. 64:417–421.
  • Munk-Olsen T, Laursen TM, Videbech P, Mortensen PB, Rosenberg R. 2007. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry. 190:435–439.
  • Peltzman T, Shiner B, Watts BV. 2020. Effects of electroconvulsive therapy on short-term suicide mortality in a risk-matched patient population. J Ect. 36:187–192.
  • Plana-Ripoll O, Pedersen CB, Agerbo E, Holtz Y, Erlangsen A, Canudas-Romo V, Anderson PK, Charlson FJ, Christensen MK, Erskine HE, et al. 2019. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet Lond Engl. 394:1827–1835.
  • Pullen SJ, Rasmussen KG, Angstman ER, Rivera F, Mueller PS. 2011. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram. J Ect. 27:192–200.
  • Rivera FA, Lapid MI, Sampson S, Mueller PS. 2011. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function. J Ect. 27:207–213.
  • Rozing MP, Jørgensen MB, Osler M. 2019. Electroconvulsive therapy and later stroke in patients with affective disorders. Br J Psychiatry. 214:168–170.
  • Schak KM, Mueller PS, Barnes RD, Rasmussen KG. 2008. The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics. 49:208–211.
  • Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. 2015. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 7:449–490.
  • Torring N, Sanghani SN, Petrides G, Kellner CH, Ostergaard SD. 2017. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand. 135:388–397.
  • Uk Ect Review Group. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 361:799–808.
  • Weiss A, Hussain S, Ng B, Sarma S, Tiller J, Waite S, Loo C. 2019. Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Aust N Z J Psychiatry. 53(7):609–623.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.